Q4 Net Sales Growth
Net sales for Q4 increased 10.5% to $1.143 billion from $1.034 billion in the prior year; organic net sales growth was 9.7%.
Full-Year Revenue Milestone and Organic Growth
Full-year 2025 organic revenue grew 9.1%, and total revenue exceeded $4.0 billion for the first time in company history.
Adjusted EBITDA and EPS Strength
Q4 adjusted EBITDA was $80.3 million versus $68.2 million a year ago (approximately +17.7% YoY). Full-year adjusted EBITDA increased ~18% and adjusted EPS grew 29% versus 2024; adjusted EBITDA margin reported at 6.2% (full-year).
Gross Profit Dollar and Efficiency Improvements
Gross profit increased 10.2% in Q4 to $276.6 million. Trailing twelve months gross profit dollars per route improved 6.2% versus FY2024 and 7.4% versus 2023. TTM adjusted EBITDA per employee rose 13% versus FY2024.
Operating Expense Leverage
Adjusted operating expenses increased only 7.4% YoY for the quarter and were 17.2% of net sales; adjusted operating expenses as a percentage of gross profit improved 176 basis points versus FY2024 (200 bps vs 2023), indicating continued operating leverage.
Key Category and Customer Metrics (Specialty)
Organic specialty sales were up 6.4% YoY driven by unique placement growth of 4.2% and reported specialty case growth of 3.3% (5.4% specialty case growth excluding the Texas produce program). Unique customers grew 1.2% YoY (approximately 3.5% excluding the Texas poultry attrition).
Balance Sheet, Liquidity and Capital Actions
Quarter-end liquidity was $280.5 million (including $121 million cash and $159.5 million availability under ABL). Net debt was approximately $529.5 million with net debt to adjusted EBITDA about 2.1x. Management completed a term loan repricing reducing spread from 3.0% to 2.5% and continues returning cash to shareholders via opportunistic buybacks.
Strategic Investments and M&A
Continued investment in distribution capacity, facility consolidations, and strategic M&A (notably Italco Specialty Foods in Colorado). Management emphasized ongoing targeted M&A and reinvestment to expand market footprint.
2026 Guidance
Management provided full-year 2026 guidance: net sales $4.35B–$4.45B, gross profit $1.053B–$1.076B, and adjusted EBITDA $276M–$286M (guidance implies mid-single-digit revenue growth cadence and continued operating leverage).